2020 Early Detection Seminar Series

Seminar & Discussion: 11:00am - 12:00pm

Reception: 12:00pm - 12:30pm

The Canary Center at Stanford for Cancer Early Detection is committed to fundamental discovery and translation of novel early cancer detection and prognostication strategies. We have brought together scientists, physicians, and engineers to think outside the box to create new solutions for cancer early detection. The Canary Center hosts a seminar series, CEDSS, that presents seminars highlighting new research in Early Cancer Detection. These seminars are open and free to everyone in the Stanford community. 

Note: This seminar does not run through the Summer months.

October 15, 2020

Zoom Meeting

Meeting URL: https://stanford.zoom.us/s/93515779500
Dial: +1 650 724 9799 or +1 833 302 1536
Meeting ID: 935 1577 9500
Meeting Passcode: 767148

The Origins and Detection of
Lethal Prostate Cancer

Paul C. Boutros, PhD, MBA

Professor of Urology and of Human Genetics
Director of Cancer Data Science
Associate Director of Cancer Informatics
University of California, Los Angeles

Boutros earned his B.Sc. degree from the University of Waterloo in Chemistry in 2004, and his Ph.D. degree from the University of Toronto, Canada, in Medical Biophysics in 2008. At Toronto, he also earned an executive M.B.A. from the Rothman School of Management. In 2008, Boutros started his independent research career at the Ontario Institute for Cancer Research first as a fellow (2008–2010) and then as principal investigator (2010–2018). He moved to California to join the UCLA faculty in 2018.

RSVP:  https://www.onlineregistrationcenter.com/PBoutros

Previous 2020 Seminars

May 26, 2020

Zoom Meeting

Meeting URL: https://stanford.zoom.us/j/230531527
Dial: +1 650 724 9799 (US, Canada, Caribbean Toll) or
+1 833 302 1536 (US, Canada, Caribbean Toll Free)
Meeting ID: 230 531 527

Multicancer detection of early-stage cancers with simultaneous tissue localization using a plasma cfDNA-based targeted methylation assay

Eric Fung, MD, PhD

Senior Medical Director
GRAIL, Inc.